Pancreatic Neuroendocrine Neoplasm Associated with a Familial MAX Deletion

Autor: Vinciane Dideberg, Esther Korpershoek, Sandrine Petignot, Vincent Bours, Emilie Castermans, Pablo Beckers, Adrian Daly, Albert Beckers, Vincent Rohmer, Irène Scagnol

Publikováno v: Hormone & Metabolic Research, 52(11), 784-787. Georg Thieme Verlag

Most pancreatic neuroendocrine neoplasms (pNEN) occur sporadically but they can also occur as part of multiple endocrine neoplasia type 1 (MEN1). MAX was originally described as an inherited pheochromocytoma-paraganglioma risk gene, but also has rece

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46b0773a2b22897bbe9969de28e5fdc2
https://doi.org/10.1055/a-1186-0790

Histologically Proven Bronchial Neuroendocrine Tumors in MEN1: A GTE 51-Case Cohort Study

Autor: J. Guigay, Catherine Cardot-Bauters, Patricia Niccoli, H. Du Boullay, B. Delemer, M. Le Bras, Catherine Lombard-Bohas, Olivier Chabre, Pierre B. A. Lecomte, Jean-Yves Scoazec, Christine Binquet, Ph. Caron, P. Chanson, Marc Klein, Carmen Vulpoi, Pierre Goudet, F. Borson-Chazot, T. Aparicio, Vincent Rohmer, E. Cosson, Albert Beckers, I. Guilhem, Eric Baudin, Bruno Vergès, A. Tabarin

Publikováno v: World Journal of Surgery
World Journal of Surgery, Springer Verlag, 2018, 42 (1), pp.143-152. ⟨10.1007/s00268-017-4135-z⟩
World Journal of Surgery, Springer Verlag, 2018, 42 (1), pp.143-152. 〈https://link.springer.com/article/10.1007%2Fs00268-017-4135-z#enumeration〉. 〈10.1007/s00268-017-4135-z〉

IF 2.673; International audience; ObjectiveTo evaluate the natural history of MEN1-related bronchial endocrine tumors (br-NETs) and to determine their histological characteristics, survival and causes of death.Summary background databr-NETs frequency

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d98736ccd83e87b8902168191cb719ac
https://doi.org/10.1007/s00268-017-4135-z

A randomized doubled blind phase II study exploring the safety and efficacy of nintedanib (BIBF1120) as second line therapy for patients (pts) with differentiated thyroid carcinoma (DTC) progressing after first line therapy: EORTC 1209

Autor: Patrick Schöffski, Sylvie Zanetta, Barbara Jarzab, Vincent Rohmer, Oliver Bechter, Lars Bastholt, Ellen Kapiteijn, Sandrine Marreaud, Martin Schlumberger, Kate Newbold, Laura D. Locati, Baktiar Hasan, Yann Godbert, Sophie Leboulleux, Salvatore Domenico, Samson Assele, Lisa Licitra, Jaume Capdevila

Publikováno v: Schlumberger, M, Newbold, K, Hasan, B, Marreaud, S, Assele, S, Licitra, L, Schoffski, P, Leboulleux, S, Locati, L D, Godbert, Y, Rohmer, V, Jarzab, B, Domenico, S, Bechter, O E, Zanetta, S, Capdevila, J, Kapiteijn, E & Bastholt, L 2018, ' A randomized doubled blind phase II study exploring the safety and efficacy of nintedanib (BIBF1120) as second line therapy for patients (pts) with differentiated thyroid carcinoma (DTC) progressing after first line therapy: EORTC 1209 ', Journal of Clinical Oncology, vol. 36, no. 15 Suppl., pp. 6021 . https://doi.org/10.1200/JCO.2018.36.15_suppl.6021

6021Background: Radioiodine refractory advanced DTC may benefit from treatment with TKI. Most DTC pts will ultimately progress after treatment with a TKI and those in good general condition are can...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::033365ace7347ad4d90969fb39b3f2a1
https://portal.findresearcher.sdu.dk/da/publications/4e609732-731d-42c9-9778-b207ba607800

Vandetanib for the Treatment of Advanced Medullary Thyroid Cancer Outside a Clinical Trial: Results from a French Cohort

Autor: Sophie Leboulleux, Delphine Drui, Claire Schvartz, Françoise Bonichon, Martin Schlumberger, Cecile N Chougnet, Christelle De La Fouchardiere, Vincent Rohmer, Bruno Chauffert, Isabelle Borget, Patricia Niccoli, Lise Crinière, Sylvie Zanetta, Olivier Schneegans, Stéphane Bardet

Publikováno v: Thyroid
Thyroid, Mary Ann Liebert, 2015, 25 (4), pp.386-391. ⟨10.1089/thy.2014.0361⟩

International audience; BACKGROUND:A randomized phase III trial demonstrated that vandetanib treatment is effective in patients with metastatic medullary thyroid cancer (MTC), leading to regulatory approval, but its use may be associated with toxicit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a449cbe5d8cf18888d5c5e9b74f6f72
https://doi.org/10.1089/thy.2014.0361

Nationwide French Study of RET Variants Detected from 2003 to 2013 Suggests a Possible Influence of Polymorphisms as Modifiers

Autor: Anne-Paule Gimenez-Roqueplo, Maylis Lebeault, Marie Chabbert, Chantal Delvincourt, Stéphane Pinson, Pauline Romanet, Nathalie Bouzamondo, Véronique Barbu, Anne Barlier, Vincent Rohmer, Patrick Saulnier, Jean-Marc Rey, Françoise Borson-Chazot, Julien Blin, Pascal Pigny, Stephane Bezieau, Charlotte Veyrat-Durebex, Alain Carrie, Sophie Giraud, Marine Guillaud-Bataille, Delphine Mirebeau-Prunier, Amira Mohamed

Publikováno v: Thyroid
Thyroid, Mary Ann Liebert, 2017, 27 (12), pp.1511-1522. ⟨10.1089/thy.2016.0399⟩
Thyroid, 2017, 27 (12), pp.1511-1522. ⟨10.1089/thy.2016.0399⟩

International audience; Background: The presence of single nucleotide polymorphisms (SNPs) in the REarranged during Transfection (RET) gene has been investigated with regard to their potential role in the development or progression of medullary thyro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6210177383a35cd89305eb8b0d520375
https://pubmed.ncbi.nlm.nih.gov/28946813